These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1107 related articles for article (PubMed ID: 2160060)
1. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
2. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. Bowen R; Haslam RJ J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604 [TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP. Fisch A; Michael-Hepp J; Meyer J; Darius H Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414 [TBL] [Abstract][Full Text] [Related]
4. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation. Zahavi M; Zahavi J; Kakkar VV Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo. Gerzer R; Drummer C; Karrenbrock B; Heim JM J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Gordge MP; Hothersall JS; Noronha-Dutra AA Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353 [TBL] [Abstract][Full Text] [Related]
7. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308 [TBL] [Abstract][Full Text] [Related]
8. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate. Vanderwel M; Haslam RJ J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338 [TBL] [Abstract][Full Text] [Related]
9. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Yu SM; Kuo SC Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926 [TBL] [Abstract][Full Text] [Related]
10. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets. Matsuoka I; Suzuki T J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364 [TBL] [Abstract][Full Text] [Related]
11. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation. Bult H; Fret HR; Herman AG J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase]. Karrenbrock B; Grewe R; Loeschke K; Gerzer R Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462 [TBL] [Abstract][Full Text] [Related]
13. Nitrovasodilators and cGMP inhibit human platelet activation. Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148 [TBL] [Abstract][Full Text] [Related]
15. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation. Dickinson NT; Jang EK; Haslam RJ Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):371-7. PubMed ID: 9163326 [TBL] [Abstract][Full Text] [Related]
16. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation. Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
19. Refractoriness of platelets to prostaglandins after infusion in rabbits. Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]